top of page
  • Facebook
  • Twitter
  • Instagram
Newcorn Headshot.jpg

Jeffrey Newcorn, MD
Professor of Psychiatry and Pediatrics; Director, Division of ADHD and Learning Disorders; Center of Excellence in
ADHD and Learning Disorders
Icahn School of Medicine at Mount Sinai

Use of Digital Therapeutics in the Treatment of

Children and Adults with ADHD
Friday,  February 12, 2027
10:15 AM - 11:15 AM

Jeffrey Newcorn, MD Professor of Psychiatry and Pediatrics; Director of the Division of ADHD and Learning Disorders, and the Center for Excellence in ADHD and Learning Disorders; Icahn School of Medicine at Mount Sinai; Director, Pediatric Psychopharmacology, Mount Sinai Health System Dr. Newcorn is a highly regarded researcher in the areas of ADHD, aggression, and child and adolescent psychopharmacology, whose work spans clinical and translational topics. 

​

He has been the Principal Investigator or Co-investigator on numerous NIH-funded grants that examine the clinical, genetic, neuroanatomic and neurophysiologic basis of ADHD its treatment, including the landmark MTA Study. He directs an active clinical trials program and has studied many of the current and emerging medications for ADHD. He is an internationally recognized educator, and is an editorial board member of several leading child psychiatry/psychology and psychopharmacology journals. Dr. Newcorn has published over 400 articles and book chapters; he has received numerous awards for his work, including the Hulse Award from the New York Council on Child and Adolescent Psychiatry, the Elaine Schlosser Lewis Award for research in Attention Deficit Disorder from the American Academy of Child and Adolescent Psychiatry, and the Blanche F. Ittleson award for research in Child and Adolescent Psychiatry from the American Psychiatric Association. He was elected to the CHADD Hall of Fame in 2014. He was a founding board member of the American Professional Society for ADHD and Related Disorders, serving as President from 2020-2022.
 

Lecture Summary:

TBD

​Goals and Learning Objectives:

  • TBD

​

Disclosures:

TBD

bottom of page